SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,355,290 | +98.6% | 66,030 | +88.5% | 0.49% | +89.1% |
| Q3 2022 | $1,186,000 | -63.2% | 35,026 | -35.0% | 0.26% | -49.3% |
| Q2 2018 | $3,227,000 | +36.8% | 53,910 | -8.6% | 0.51% | +62.1% |
| Q3 2017 | $2,359,000 | -28.6% | 58,967 | -23.1% | 0.31% | -42.5% |
| Q2 2017 | $3,305,000 | -7.0% | 76,692 | -46.6% | 0.55% | +14.5% |
| Q3 2016 | $3,553,000 | -7.4% | 143,679 | -23.7% | 0.48% | -17.3% |
| Q2 2016 | $3,835,000 | +20.5% | 188,277 | -20.5% | 0.58% | +38.7% |
| Q4 2015 | $3,183,000 | +5.4% | 236,833 | +10.0% | 0.42% | -13.0% |
| Q3 2015 | $3,020,000 | -35.0% | 215,265 | -21.3% | 0.48% | -12.0% |
| Q2 2015 | $4,644,000 | – | 273,517 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |